WCLC 2022 Conference Coverage

 

WCLC 2022 Conference Coverage
G

Lecture Summary - Sotorasib in Combination With RMC-4630, a SHP2 Inhibitor, in KRAS p.G12C-Mutated NSCLC and Other Solid Tumors

By WCLC 2022 Conference Coverage FEATURING Gerald Falchook
By WCLC 2022 Conference Coverage FEATURING Gerald Falchook
10 views
September 16, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

09:36
Johnson & Johnson

Mechanisms of Resistance in Locally Advanced or Metastatic EGFR+ NSC…

Feat. J. Heymach, M. Das

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse
Videos
01:43
WCLC 2022 Conference Coverage

Lecture Summary - EGFR Testing in Practices, Treatment Choice, and C…

Feat. J. Subramanian
09:45
WCLC 2022 Conference Coverage

EGFR Testing in Practices, Treatment Choice, and Clinical Outcomes i…

Feat. J. Subramanian
16:55
WCLC 2022 Conference Coverage

WCLC 2022: Early Stage NSCLC Highlights

Feat. R. Shah
40
WCLC 2022 Conference Coverage

Lecture Summary - Amivantamab and Lazertinib in Treatment-Naive EGFR…

Feat. B. Chul Cho
08:49
WCLC 2022 Conference Coverage

Amivantamab and Lazertinib in Treatment-Naïve EGFRm NSCLC

Feat. B. Chul Cho
53
WCLC 2022 Conference Coverage

Lecture Summary - Sotorasib in Combination With RMC-4630, a SHP2 Inh…

Feat. G. Falchook
07:16
WCLC 2022 Conference Coverage

Sotorasib in Combination With RMC-4630, a SHP2 Inhibitor, in KRAS p.…

Feat. G. Falchook
45
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022: Does Quitting Smoking After a Diagnosis…

Feat. J. Jassem
09:43
WCLC 2022 Conference Coverage

WCLC 2022: Does Quitting Smoking After a Diagnosis of Lung Cancer Im…

Feat. J. Jassem
13:46
WCLC 2022 Conference Coverage

Predictive Biomarkers for Immunotherapy in Lung Cancer

Feat. F. Hirsch
06:00
WCLC 2022 Conference Coverage

WCLC 2022 on the Phase 2 Study of Pevonedistat in Combination With C…

Feat. R. Millett
39
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on the Use of Medical Cannabis Concomita…

Feat. B. Waissengrin
04:19
WCLC 2022 Conference Coverage

WCLC 2022 on the Use of Medical Cannabis Concomitantly With Immune C…

Feat. B. Waissengrin
11:15
WCLC 2022 Conference Coverage

WCLC 2022 on the ADAURA2 Phase III Study: Adjuvant Osimertinib vs. P…

Feat. T. van der Gronde
40
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on Ipilimumab and Nivolumab in Pretreate…

Feat. M. Jakopovic
16:56
WCLC 2022 Conference Coverage

WCLC 2022 on Ipilimumab and Nivolumab in Pretreated Patients With Ma…

Feat. M. Jakopovic
44
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on the Role of Nanoparticle Polymeric Mi…

Feat. B. Han
08:25
WCLC 2022 Conference Coverage

WCLC 2022 on the Role of Nanoparticle Polymeric Micellar Paclitaxel …

Feat. B. Han
39
WCLC 2022 Conference Coverage

Lecture Summary - A Phase II Study of Metformin With Pemetrexed/Carb…

Feat. S. Verma
08:09
WCLC 2022 Conference Coverage

A Phase II Study of Metformin With Pemetrexed/Carboplatin in Metasta…

Feat. S. Verma
01:07
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on Cancer and Atopy: Parallel Drivers? I…

Feat. T. Marron
11:14
WCLC 2022 Conference Coverage

WCLC 2022 on Cancer and Atopy: Parallel Drivers? IL-4 Blockade Syner…

Feat. T. Marron
09:56
WCLC 2022 Conference Coverage

WCLC 2022 Efficacy of 1L Immune Checkpoint Inhibitors in Advanced NS…

Feat. Y. Uehara
41
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on Molecular Diagnostics in Clinical Pra…

Feat. U. Malapelle
04:50
WCLC 2022 Conference Coverage

WCLC 2022 on Molecular Diagnostics in Clinical Practice for NSCLC

Feat. U. Malapelle
05:34
WCLC 2022 Conference Coverage

WCLC 2022 on the Phase II DOLPHIN Study: Durvalumab + Concurrent RT …

Feat. M. Tachihara
02:26
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022: A Multi-Omics Approach for Delineating …

Feat. A. Kulasinghe
12:07
WCLC 2022 Conference Coverage

WCLC 2022: A Multi-Omics Approach for Delineating Tissue Signatures …

Feat. A. Kulasinghe
56
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on Socio-Economic Inequalities in NSCLC …

Feat. R. Norris
12:35
WCLC 2022 Conference Coverage

WCLC 2022 on Socio-Economic Inequalities in NSCLC Treatment During t…

Feat. R. Norris
16:09
WCLC 2022 Conference Coverage

WCLC 2022 on Biomarker Identification of Hard-to-Treat NSCLC Patient…

Feat. N. Reinmuth
50
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022: All You Need to Know About KRAS in NSCLC

Feat. O. Terje Brustugun
16:26
Odd Terje Brustugun

All You Need to Know About KRAS in NSCLC

05:52
WCLC 2022 Conference Coverage

WCLC 2022 on the Progression Pattern, Resistance Mechanism, and Subs…

Feat. Z. Zou
12:55
WCLC 2022 Conference Coverage

WCLC 2022 on the Impact of Radiation Dose to the Immune Cells in Unr…

Feat. N. McCall
49
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 Impact of Precision Medicine Methods on …

Feat. C. Vakkalagadda
07:06
WCLC 2022 Conference Coverage

WCLC 2022 Impact of Precision Medicine Methods on 1L Therapies in mN…

Feat. C. Vakkalagadda
01:10
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on Frequency and Detectability of Uncomm…

Feat. H. O'Sullivan
04:06
WCLC 2022 Conference Coverage

WCLC 2022 on Frequency and Detectability of Uncommon EGFR Mutations …

Feat. H. O'Sullivan
51
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 Phase II Study of ctDNA Directed Consoli…

Feat. I. Mohamed
10:44
WCLC 2022 Conference Coverage

WCLC 2022 Phase II Study of ctDNA Directed Consolidation Durvalumab …

Feat. I. Mohamed
01:22
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on KEYNOTE B36: A Pilot Study of 1L Tumo…

Feat. R. Kotecha
09:13
WCLC 2022 Conference Coverage

WCLC 2022 on KEYNOTE B36: A Pilot Study of 1L Tumor Treating Fields …

Feat. R. Kotecha
01:43
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on Modifiable Biomarkers of Response to …

Feat. D. Spakowicz
10:17
WCLC 2022 Conference Coverage

WCLC 2022 on Modifiable Biomarkers of Response to Immune Checkpoint …

Feat. D. Spakowicz
01:01
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 Impact of PET/CT-Derived Metabolic Param…

Feat. G. Lamberti
04:28
WCLC 2022 Conference Coverage

WCLC 2022 Impact of PET/CT-Derived Metabolic Parameters on Outcomes …

Feat. G. Lamberti
01:34
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 Update From the European EXOTIC Registry…

Feat. G. Mountzios
13:13
WCLC 2022 Conference Coverage

WCLC 2022 Update From the European EXOTIC Registry on Exon-20 EGFR M…

Feat. G. Mountzios
46
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022: BBT-176, a 4th Gen EGFR TKI, for Progre…

Feat. S. Min Lim
06:23
WCLC 2022 Conference Coverage

WCLC 2022: BBT-176, a 4th Gen EGFR TKI, for Progressed NSCLC After E…

Feat. S. Min Lim
48
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on the Phase II NAUTIKA1 Study of Target…

Feat. J. Lee
07:38
WCLC 2022 Conference Coverage

WCLC 2022 on the Phase II NAUTIKA1 Study of Targeted Therapies in St…

Feat. J. Lee
12:41
WCLC 2022 Conference Coverage

WCLC 2022 on Optimum Surgical Staging and Tissue Acquisition for Adj…

Feat. P. Ugalde Figueroa
34
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 Molecular Profiling and Biomarkers in Lu…

Feat. A. Sexton-Oates
11:51
WCLC 2022 Conference Coverage

WCLC 2022 Molecular Profiling and Biomarkers in Lung NET

Feat. A. Sexton-Oates
01:06
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022: Adding Alectinib Rescues Progression on…

Feat. E. Urbanska
08:52
WCLC 2022 Conference Coverage

WCLC 2022: Adding Alectinib Rescues Progression on Osimertinib Due t…

Feat. E. Urbanska
02:39
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on the Role of Completion Lobectomy Foll…

Feat. A. Turna
07:56
WCLC 2022 Conference Coverage

WCLC 2022 on the Role of Completion Lobectomy Following Sublobar Res…

Feat. A. Turna
01:32
WCLC 2022 Conference Coverage

Lecture Summary - WCLC on Prevalence and Outcomes of EGFR Exon 20 In…

Feat. A. Mittal
07:31
WCLC 2022 Conference Coverage

WCLC on Prevalence and Outcomes of EGFR Exon 20 Insertion Mutation i…

Feat. A. Mittal
40
WCLC 2022 Conference Coverage

Lacture Summary - WCLC 2022 on the Single Arm Phase II Study PEMMELA…

Feat. L. Huaqing Douma
07:16
WCLC 2022 Conference Coverage

WCLC 2022 on the Single Arm Phase II Study PEMMELA: Pembrolizumab + …

Feat. L. Huaqing Douma
40
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on Differential Diagnosis of Pneumonitis…

Feat. A. Traverso
13:19
WCLC 2022 Conference Coverage

WCLC 2022 on Differential Diagnosis of Pneumonitis in mNSCLC Pts Rec…

Feat. A. Traverso
35
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on 1L Chemotherapy vs. Chemoimmunotherap…

Feat. L. Meng
04:11
WCLC 2022 Conference Coverage

WCLC 2022 on 1L Chemotherapy vs. Chemoimmunotherapy in Stage IV LCNE…

Feat. L. Meng
52
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022: Could MRD Change Our Clinical Practice?…

Feat. A. Chaudhuri
17:11
WCLC 2022 Conference Coverage

WCLC 2022: Could MRD Change Our Clinical Practice? North American Pe…

Feat. A. Chaudhuri
07:18
WCLC 2022 Conference Coverage

WCLC 2022 on the NADIM II Trial: Pre-Treatment ctDNA Levels Signific…

Feat. A. Romero
12:46
WCLC 2022 Conference Coverage

WCLC 2022 Immunotherapy in Oncogene-Addicted NSCLC

Feat. F. Passiglia
06:45
WCLC 2022 Conference Coverage

WCLC 2022 on the Phase 3 SANOVO Study: Savolitinib or Placebo in Com…

Feat. Q. Zhou
56
WCLC 2022 Conference Coverage

Lecture Summary - WCLC 2022 on MRD Status Affecting Decisions on Adj…

Feat. F. Cappuzzo
11:20
WCLC 2022 Conference Coverage

WCLC 2022 on MRD Status Affecting Decisions on Adjuvant Therapy in N…

Feat. F. Cappuzzo
09:33
WCLC 2022 Conference Coverage

WCLC 2022 Prognostic Factors in Curative Intent Stage I Lung Adenoca…

Feat. V. Silva
05:50
WCLC 2022 Conference Coverage

WCLC 2022 on Early Detection Plus Timely Surgery Remains the Standar…

Feat. E. Taioli